Caterina Strambio De Castillia
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metadata | 6 | 2021 | 14 | 2.560 |
Why?
|
| Microscopy | 8 | 2026 | 94 | 1.840 |
Why?
|
| Software | 8 | 2021 | 388 | 1.350 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2023 | 677 | 1.240 |
Why?
|
| Nuclear Pore | 4 | 2013 | 23 | 1.020 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2013 | 114 | 0.870 |
Why?
|
| Nuclear Envelope | 7 | 2013 | 49 | 0.860 |
Why?
|
| Checklist | 2 | 2026 | 75 | 0.830 |
Why?
|
| Cell Nucleus | 6 | 2023 | 634 | 0.830 |
Why?
|
| Microscopy, Confocal | 2 | 2021 | 239 | 0.780 |
Why?
|
| Computational Biology | 2 | 2021 | 357 | 0.770 |
Why?
|
| Publishing | 1 | 2023 | 93 | 0.750 |
Why?
|
| Programming Languages | 1 | 2021 | 14 | 0.730 |
Why?
|
| Microscopy, Fluorescence | 1 | 2021 | 402 | 0.640 |
Why?
|
| Mobile Applications | 1 | 2021 | 140 | 0.620 |
Why?
|
| Nuclear Pore Complex Proteins | 5 | 2013 | 29 | 0.580 |
Why?
|
| Reproducibility of Results | 8 | 2026 | 1683 | 0.550 |
Why?
|
| HIV-1 | 7 | 2019 | 725 | 0.540 |
Why?
|
| Nuclear Proteins | 6 | 2013 | 785 | 0.530 |
Why?
|
| Proteomics | 4 | 2015 | 294 | 0.500 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2013 | 567 | 0.490 |
Why?
|
| Saccharomyces cerevisiae Proteins | 4 | 2013 | 446 | 0.480 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2017 | 147 | 0.450 |
Why?
|
| Cytoplasm | 3 | 2013 | 279 | 0.420 |
Why?
|
| Quality Control | 3 | 2021 | 74 | 0.400 |
Why?
|
| Chromatin | 4 | 2023 | 616 | 0.380 |
Why?
|
| Virion | 3 | 2019 | 121 | 0.360 |
Why?
|
| Biomedical Research | 3 | 2024 | 270 | 0.360 |
Why?
|
| Anti-HIV Agents | 2 | 2010 | 156 | 0.360 |
Why?
|
| Data Mining | 2 | 2021 | 38 | 0.350 |
Why?
|
| Chromatography, Liquid | 3 | 2017 | 129 | 0.350 |
Why?
|
| User-Computer Interface | 2 | 2021 | 126 | 0.340 |
Why?
|
| Medical Informatics | 2 | 2021 | 73 | 0.340 |
Why?
|
| Retroviridae | 3 | 2011 | 74 | 0.330 |
Why?
|
| Cyclosporine | 1 | 2010 | 77 | 0.320 |
Why?
|
| Virus Assembly | 1 | 2010 | 53 | 0.310 |
Why?
|
| Virus Replication | 3 | 2020 | 324 | 0.310 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2010 | 60 | 0.300 |
Why?
|
| RNA | 1 | 2013 | 429 | 0.300 |
Why?
|
| Carrier Proteins | 4 | 2011 | 709 | 0.280 |
Why?
|
| Cell Line | 7 | 2021 | 2057 | 0.270 |
Why?
|
| Peptides | 2 | 2015 | 590 | 0.270 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 1622 | 0.260 |
Why?
|
| Genome | 2 | 2023 | 276 | 0.250 |
Why?
|
| Research Report | 1 | 2026 | 28 | 0.240 |
Why?
|
| Animals | 10 | 2023 | 20967 | 0.240 |
Why?
|
| Dendritic Cells | 4 | 2017 | 529 | 0.240 |
Why?
|
| Biotin | 1 | 2005 | 54 | 0.230 |
Why?
|
| Cyclophilin A | 2 | 2019 | 34 | 0.230 |
Why?
|
| Calibration | 2 | 2021 | 67 | 0.220 |
Why?
|
| Biochemistry | 1 | 2005 | 50 | 0.220 |
Why?
|
| Proteome | 2 | 2015 | 155 | 0.220 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 179 | 0.220 |
Why?
|
| Humans | 24 | 2026 | 64283 | 0.220 |
Why?
|
| Tripartite Motif Proteins | 4 | 2019 | 42 | 0.210 |
Why?
|
| Capsid Proteins | 2 | 2019 | 103 | 0.210 |
Why?
|
| Peptide Fragments | 2 | 2017 | 417 | 0.210 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 463 | 0.200 |
Why?
|
| Algorithms | 2 | 2021 | 1029 | 0.200 |
Why?
|
| RNA, Viral | 3 | 2019 | 276 | 0.190 |
Why?
|
| Research Design | 1 | 2026 | 583 | 0.190 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2019 | 224 | 0.190 |
Why?
|
| Systems Integration | 1 | 2021 | 27 | 0.180 |
Why?
|
| Pattern Recognition, Automated | 1 | 2021 | 53 | 0.180 |
Why?
|
| Yeasts | 1 | 2002 | 49 | 0.180 |
Why?
|
| Societies, Scientific | 1 | 2021 | 36 | 0.180 |
Why?
|
| Fungal Proteins | 3 | 1999 | 149 | 0.180 |
Why?
|
| Workflow | 1 | 2021 | 71 | 0.170 |
Why?
|
| Congresses as Topic | 1 | 2021 | 79 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2009 | 495 | 0.170 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 71 | 0.170 |
Why?
|
| Capsid | 2 | 2011 | 97 | 0.170 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2020 | 8 | 0.170 |
Why?
|
| Carbazoles | 1 | 2020 | 14 | 0.170 |
Why?
|
| Carbamates | 1 | 2020 | 26 | 0.170 |
Why?
|
| Databases, Factual | 2 | 2021 | 856 | 0.170 |
Why?
|
| Data Collection | 1 | 2021 | 384 | 0.160 |
Why?
|
| Proteins | 1 | 2005 | 760 | 0.160 |
Why?
|
| Cryoelectron Microscopy | 1 | 2021 | 207 | 0.160 |
Why?
|
| Spindle Apparatus | 2 | 2013 | 124 | 0.150 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 266 | 0.150 |
Why?
|
| DNA | 1 | 2023 | 844 | 0.140 |
Why?
|
| Vesicular Transport Proteins | 1 | 1999 | 115 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2020 | 329 | 0.140 |
Why?
|
| Amino Acid Sequence | 7 | 2015 | 1597 | 0.130 |
Why?
|
| Molecular Sequence Data | 7 | 2015 | 1999 | 0.130 |
Why?
|
| Cytokines | 1 | 2020 | 945 | 0.130 |
Why?
|
| Membrane Proteins | 3 | 1999 | 909 | 0.130 |
Why?
|
| HeLa Cells | 4 | 2020 | 542 | 0.120 |
Why?
|
| Cell Fractionation | 1 | 1995 | 32 | 0.120 |
Why?
|
| Protein Transport | 2 | 2015 | 405 | 0.120 |
Why?
|
| Analytic Sample Preparation Methods | 1 | 2015 | 4 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2013 | 1552 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2015 | 303 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 248 | 0.110 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 446 | 0.110 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2013 | 127 | 0.100 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2013 | 14 | 0.100 |
Why?
|
| Virus Uncoating | 1 | 2013 | 2 | 0.100 |
Why?
|
| Virology | 1 | 2013 | 15 | 0.100 |
Why?
|
| Monocytes | 2 | 2015 | 357 | 0.100 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 136 | 0.100 |
Why?
|
| Mason-Pfizer monkey virus | 1 | 1992 | 2 | 0.100 |
Why?
|
| RNA Transport | 1 | 2013 | 31 | 0.100 |
Why?
|
| Ribonucleoproteins | 1 | 2013 | 116 | 0.100 |
Why?
|
| Mice | 3 | 2023 | 11004 | 0.100 |
Why?
|
| Cell Polarity | 1 | 2013 | 109 | 0.090 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 82 | 0.090 |
Why?
|
| Interleukin-15 Receptor alpha Subunit | 1 | 2011 | 2 | 0.090 |
Why?
|
| Interleukin-15 | 1 | 2011 | 25 | 0.090 |
Why?
|
| Microscopy, Electron | 3 | 1999 | 251 | 0.090 |
Why?
|
| Models, Biological | 2 | 2010 | 1187 | 0.090 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 84 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 645 | 0.080 |
Why?
|
| Infectious Anemia Virus, Equine | 1 | 2009 | 2 | 0.080 |
Why?
|
| Leukemia Virus, Murine | 1 | 2009 | 30 | 0.070 |
Why?
|
| Biological Transport | 3 | 1999 | 291 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 329 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2011 | 679 | 0.060 |
Why?
|
| Trypsin | 2 | 2017 | 42 | 0.060 |
Why?
|
| Ions | 2 | 2017 | 57 | 0.060 |
Why?
|
| Sepharose | 1 | 2005 | 7 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 365 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2005 | 49 | 0.060 |
Why?
|
| Primary Cell Culture | 2 | 2015 | 79 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2005 | 140 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2011 | 803 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 1019 | 0.060 |
Why?
|
| Publications | 1 | 2024 | 29 | 0.050 |
Why?
|
| Proteolysis | 2 | 2015 | 149 | 0.050 |
Why?
|
| Temperature | 1 | 2005 | 312 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 462 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2177 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 1164 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2023 | 167 | 0.050 |
Why?
|
| Reference Standards | 1 | 2021 | 74 | 0.040 |
Why?
|
| Vero Cells | 1 | 2020 | 81 | 0.040 |
Why?
|
| Protein Binding | 3 | 2011 | 1619 | 0.040 |
Why?
|
| Reverse Transcription | 1 | 2019 | 8 | 0.040 |
Why?
|
| Reverse Genetics | 1 | 2019 | 10 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2002 | 396 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2005 | 775 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 1999 | 130 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 386 | 0.040 |
Why?
|
| Time Factors | 1 | 2005 | 3725 | 0.030 |
Why?
|
| Gene Deletion | 1 | 1999 | 312 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 1999 | 375 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2009 | 785 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 408 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1995 | 32 | 0.030 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2015 | 5 | 0.030 |
Why?
|
| Detergents | 1 | 1995 | 34 | 0.030 |
Why?
|
| Radioimmunoprecipitation Assay | 1 | 2015 | 2 | 0.030 |
Why?
|
| Trichloroacetic Acid | 1 | 2015 | 3 | 0.030 |
Why?
|
| Acetone | 1 | 2015 | 5 | 0.030 |
Why?
|
| Octoxynol | 1 | 2015 | 11 | 0.030 |
Why?
|
| Buffers | 1 | 2015 | 23 | 0.030 |
Why?
|
| Chemical Precipitation | 1 | 2015 | 12 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 183 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 2015 | 67 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2009 | 1160 | 0.030 |
Why?
|
| Solubility | 1 | 2015 | 189 | 0.030 |
Why?
|
| Benchmarking | 1 | 2015 | 134 | 0.030 |
Why?
|
| Heparin | 1 | 1995 | 116 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1995 | 614 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1163 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 1053 | 0.030 |
Why?
|
| Uridine | 1 | 2013 | 22 | 0.030 |
Why?
|
| Growth Hormone | 1 | 1992 | 18 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2013 | 126 | 0.020 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1992 | 40 | 0.020 |
Why?
|
| Phenotype | 2 | 2011 | 1223 | 0.020 |
Why?
|
| Biological Evolution | 1 | 1992 | 122 | 0.020 |
Why?
|
| Genome, Viral | 1 | 1992 | 140 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2013 | 266 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2011 | 24 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2011 | 41 | 0.020 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2011 | 144 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 1995 | 870 | 0.020 |
Why?
|
| AIDS Vaccines | 1 | 2011 | 72 | 0.020 |
Why?
|
| Transfection | 1 | 1992 | 696 | 0.020 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2011 | 36 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 82 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2011 | 106 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 386 | 0.020 |
Why?
|
| Aotidae | 1 | 2009 | 11 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 668 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 149 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2009 | 85 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2011 | 471 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 627 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 625 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 239 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 185 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 674 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 1176 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 914 | 0.020 |
Why?
|
| Microtubule-Organizing Center | 1 | 2005 | 6 | 0.010 |
Why?
|
| DNA Polymerase I | 1 | 2005 | 5 | 0.010 |
Why?
|
| Metaphase | 1 | 2005 | 36 | 0.010 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2005 | 22 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2005 | 16 | 0.010 |
Why?
|
| Cytokinesis | 1 | 2005 | 41 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 136 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 2140 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2005 | 221 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 206 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 1541 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 1197 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 3070 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1998 | 31 | 0.010 |
Why?
|
| RNA Helicases | 1 | 1998 | 95 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 2633 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 1998 | 348 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 17134 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 17921 | 0.010 |
Why?
|
| Male | 1 | 2011 | 30322 | 0.010 |
Why?
|
| Female | 1 | 2011 | 33382 | 0.000 |
Why?
|